Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
For additional details and discussion regarding pharmacologic approaches to glycemic management, please refer to the full 2020 ADA Standards of Medical Care
This is not a permanent benefit change
All participants gave written informed consent prior to participation
A question remains as to whether this therapy is effective in patients with existing HFpEF or if its primary benefit lies in impacting risk factors and associated cardiovascular diseases that contribute to the development of HFpEF
The Wegovy pill at $149/month plus $99 subscription ($248/month total) represents a meaningfully different value calculation than the injectable path
US$ 26.46
US$ 27.33
US$ 24.91
US$ 23.71
